Leveraging the Biology of Adversity and Resilience to Transform Pediatric Practice
About
The ACEs Aware Science and Innovation Speaker Series provides a forum for discussing the emerging science of toxic stress, Adverse Childhood Experiences (ACEs), and other early life adversities, as well as resilience and strength-based factors within a foundation of equity. The series highlights cutting-edge researchers and innovators in the field who have published evidence-based, community-engaged, and data-driven studies. In the first webinar in the series, Dr. Pat Levitt will present on his paper, “Leveraging the Biology of Adversity and Resilience to Transform Pediatric Practice” and a companion article, “Genes, Environments, and Time: The Biology of Adversity and Resilience”. He will discuss an interactive gene-environment-time framework, which underscores the extent to which health and development are shaped throughout life. He will discuss challenges and opportunities for clinical practice and advocacy in the early childhood ecosystem.
Learning Objectives
- Apply a framework for leveraging new scientific discoveries to inform new strategies in pediatric practice and advocacy.
- Identify increasing evidence pointing to the importance of the prenatal period and early infancy for the developing brain, immune system, and metabolic regulation.
- Recognize the extent of differences in response to early environment experiences for the child.
Professional Credit
- This activity provides the following types of credit: AMA, AAPA, APA, ANCC, ASWB, ABIM-MOC, ABP-MOC.
- 1.0 credits are available.
- Activity document
Featuring
Pat Levitt, PhD is the Simms/Mann Chair in Developmental Neurogenetics, Children’s Hospital Los Angeles (CHLA), the WM Keck Provost Professor of Neurogenetics, Keck School of Medicine, USC, and the Chief Scientific Officer, Senior Vice President and Director, the Saban Research Institute at CHLA. Dr. Levitt is a developmental neuroscientist performing studies of genes and environments that contribute to building healthy and adaptive cognitive, social, and emotional circuits. His clinical research studies focus on infants, toddlers, and their caregivers to discover objective measures of risk for toxic stress. Levitt, who has published more than 350 scientific papers, is an elected member of the National Academy of Medicine and serves on the governing board of the California Institute for Regenerative Medicine. He also serves as co-Scientific Director of the National Scientific Council on the Developing Child.